Folate-targeted drug-delivery systems prepared by nano-comminution

Drug Development and Industrial Pharmacy

Volumn 37, Issue 2, 2011, Pages 131-138

  Kim, Sujung ^a   Lee, Jonghwi ^a  

^a Chung Ang University   (South Korea)

Author keywords

Drug release; milling; nanoparticles; particle size; suspensions

Indexed keywords

CHITOSAN; FOLIC ACID; NANOPARTICLE; NAPROXEN; PACLITAXEL;

ADSORPTION; ARTICLE; CHEMICAL REACTION; CONJUGATION; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; NANOCOMMINUTION; NANOENCAPSULATION; NONHUMAN; SUSPENSION;

CHITOSAN; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; FOLIC ACID; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOPARTICLES; NAPROXEN; PACLITAXEL; PARTICLE SIZE; POLYPHOSPHATES;

EID: 79952961931     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.496788     Document Type: Article

References (32)

1. Basa S, Muniyappan T, Karatgi P, Prabhu R, Pillai R. (2008). Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Dev Ind Pharm, 34(11):1209-18.
2. Chen X, Matteucci ME, Lo CY, Johnston KP, Williams RO. (2009). Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug Dev Ind Pharm, 35(3):283-96.
3. Choi JY, Park CH, Lee J. (2008). Effect of polymer molecular weight on nanocomminution of poorly soluble drug. Drug Deliv, 15(5):347-53.
4. Crisp MT, Tucker CJ, Rogers TL, Williams RO, Johnston KP. (2007). Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals. J Control Release, 117(3):351-9. (Pubitemid 46216578)
5. Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, et al. (2006). Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release, 111(1-2):56-64. (Pubitemid 43289995)
6. Keck CM, Muller RH. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm, 62(1):3-16. (Pubitemid 41736019)
7. Lee J, Cheng Y. (2006). Critical freezing rate in freeze drying nanocrystal dispersions. J Control Release, 111(1-2):185-92. (Pubitemid 43290007)
8. Lee MK, Kim MY, Kim S, Lee J. (2009). Cryoprotectants for freeze drying of drug nano-suspensions: Effect of freezing rate. J Pharm Sci, 98:4808-17.
9. Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18(2):113-20. (Pubitemid 36184748)
10. Van Eerdenbrugh B, Van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364(1):64-75.
11. Kumar M, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. (2004). Chitosan chemistry and pharmaceutical perspectives. Chem Rev, 104(12):6017-84. (Pubitemid 40025733)
12. Rinaudo M. (2006). Chitin and chitosan: Properties and applications. Prog Polym Sci, 31:603-32. (Pubitemid 44287019)
13. Pillai CKS, Paul W, Sharma CP. (2009). Chitin and chitosan polymers: Chemistry, solubility and fiber formation. Prog Polym Sci, 31:603-32.
14. Ojha SS, Stevens DR, Hoffman TJ, Stano K, Klossner R, Scott MC, et al. (2008). Fabrication and characterization of electrospun chitosan nanofibers formed via templating with polyethylene oxide. Biomacromolecules, 9(9):2523-9.
15. Chen H, Ouyang W, Lawuyi B, Prakash S. (2006). Genipin crosslinked alginate-chitosan microcapsules: Membrane characterization and optimization of cross-linking reaction. Biomacromolecules, 7(7):2091-8. (Pubitemid 44103348)
16. Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, et al. (2006). Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27(9):2060-5. (Pubitemid 41759500)
17. Hilgenbrink AR, Low PS. (2005). Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci, 94(10):2135-46. (Pubitemid 41665275)
18. Lee J, Choi JY, Park CH. (2008). Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm, 355(1-2):328-36.
19. FDA Guidance for Industry. (2000 October). Bioavailability and bioequivalence studies for orally administered drug products- general considerations. Rockville, MD: FDA.
20. FDA Guidance for Industry. (1997 August). Dissolution testing of immediate release solid oral dosage forms. Rockville, MD: FDA.
21. FDA Guidance for Industry. (1997 September). Extended release solid oral dosage forms: Development, evaluation and application of in vitro/in vivo correlations. Rockville, MD: FDA.
22. Siewert M, Dressman J, Brown CK, Shah VP, Aiache JM, Aoyagi N, et al. (2003). FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech, 4(1):43-52.
23. Choi JY, Yoo JY, Kwak HS, Nam BU, Lee J. (2005). Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys, 5(5):472-4. (Pubitemid 40714976)
24. Kendall K. (1978). The impossibility of comminuting small particles by compression. Nature, 272:710-1.
25. Ploehn HJ, Russel WB. (1990). Interactions between colloidal particles and soluble polymers. Adv Chem Eng, 15:137-228.
26. Lee J. (2003). Drug nano- and microparticles processed into solid dosage forms: Physical properties. J Pharm Sci, 92(10):2057-68. (Pubitemid 37175635)
27. Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. (2005). Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci, 24(5):441-9. (Pubitemid 40387258)
28. Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. (2002). Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm, 249(1-2):165-74. (Pubitemid 35333443)
29. Shu XZ, Zhu KJ. (2000). A novel approach to prepare tripolyphosphate/ chitosan complex beads for controlled release drug delivery. Int J Pharm, 201(1):51-8. (Pubitemid 30364969)
30. Shu XZ, Zhu KJ. (2002). Controlled drug release properties of ionically cross-linked chitosan beads: The influence of anion structure. Int J Pharm, 233(1-2):217-25. (Pubitemid 34230434)
31. Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, et al. (2006). Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res, 23(6):1144-56. (Pubitemid 43946137)
32. Trickler WJ, Nagvekar AA, Dash AK. (2009). The in vitro subcellular localization and in vivo efficacy of novel chitosan/ GMO nanostructures containing paclitaxel. Pharm Res, 26(8):1963-73.